Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats

被引:0
|
作者
Samochowiec, J
Kleinrok, Z
JagielloWojtowicz, E
Horodnicki, J
Rommelspacher, H
Schmidt, LG
机构
[1] FREE UNIV BERLIN, DEPT CLIN NEUROBIOL, D-14050 BERLIN, GERMANY
[2] FREE UNIV BERLIN, DEPT PSYCHIAT, D-14050 BERLIN, GERMANY
[3] MED ACAD, DEPT PHARMACOL, PL-20090 LUBLIN, POLAND
[4] POMERANIAN MED ACAD, DEPT PSYCHIAT, PL-71460 SZCZECIN, POLAND
来源
POLISH JOURNAL OF PHARMACOLOGY | 1997年 / 49卷 / 04期
关键词
prolactin; ethanol; withdrawal syndrome; SKF; 38393; PPHT; SCH; 23390; pimozide;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A single dose of ethanol (1g/kg po) significantly decreased, whereas higher doses of ethanol (2 or 3 g/kg po) significantly increased the serum prolactin (PRL) concentration. Administration of ethanol at a dose of 2 g/kg po for 4 weeks did not affect this parameter but the ethanol withdrawal syndrome caused a significant rise in the serum PRL level. Chronic studies showed that D-1-dopaminergic agonist SKF 38390 (2.5 mg/kg) significantly raised serum PRL levels in rats. This effect was reversed by long-lasting treatment of rats with ethanol and ethanol withdrawal. Pimozide (1 mg/kg), D-2 antagonist, increased PRL in those rats. On the other hand, D-1-antagonist SCH 23390 (0.5 mg/kg) and D-2-agonist PPHT (0.5 mg/kg) were without effect in rats administered ethanol for a long period of time. In rats with ethanol withdrawal syndrome, administration of D-1-antagonist SCH 23390 (0.5 mg/kg) also did not affect the serum PRL concentrations. However, D-1-agonist SKF 38393 (2.5 mg/kg) and D-2-antagonist pimozide (1mg/kg) increased the serum PRL level in rats with ethanol withdrawal syndrome, whereas D-2 agonist PPHT (2 mg/kg) decreased PRL level in serum. Thus, the acute effect of ethanol on PRL level appears to be dose-dependent. It seems that chronic ethanol administration and its withdrawal especially affected D-1 receptor.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [1] INFLUENCE OF DOPAMINERGIC AGONISTS AND ANTAGONISTS ON SERUM PROLACTIN CONCENTRATIONS IN RAT
    HOROWSKI, R
    GRAF, KJ
    NEUROENDOCRINOLOGY, 1976, 22 (03) : 273 - 286
  • [2] THE EFFECTS OF DOPAMINERGIC BLOCKADE ON SERUM TSH AND PROLACTIN LEVELS IN THYROTOXICOSIS
    SWART, S
    OMALLEY, BP
    VORA, J
    BARNETT, DB
    ROSENTHAL, FD
    ACTA ENDOCRINOLOGICA, 1984, 106 (03): : 330 - 335
  • [3] EFFECTS OF ADRENERGIC AGONISTS AND ANTAGONISTS ON GROWTH OF DMBA-INDUCED MAMMARY-TUMORS AND SERUM PROLACTIN LEVELS
    HODSON, CA
    MIODUSZEWSKI, R
    MEITES, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 159 - 159
  • [4] SCREENING FOR EFFECTS OF DOPAMINERGIC AND ANTI-DOPAMINERGIC DRUGS ON SERUM PROLACTIN LEVELS BY RADIOIMMUNOASSAY (RIA)
    DOBRIN, EI
    BERG, JR
    MARES, SE
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 395 - 395
  • [5] EFFECTS OF DOPAMINERGIC AGONISTS AND ANTAGONISTS ON FEEDING IN INTACT AND 6-HYDROXYDOPAMINE-TREATED RATS
    HEFFNER, TG
    ZIGMOND, MJ
    STRICKER, EM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1977, 201 (02): : 386 - 399
  • [6] Effects of dopaminergic agonists on eyeblinking in rats
    Paronis, CA
    Belesis, M
    Kim, R
    Minneman, JA
    FASEB JOURNAL, 2003, 17 (04): : A204 - A204
  • [7] Effects of dopaminergic agonists and antagonists on the muscarinic and dopaminergic receptors from rat neostriatum
    deSousa, FCF
    Marinho, MMF
    Macedo, DS
    Gomes, PB
    Viana, GSB
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 1997, 116 (03): : 197 - 203
  • [8] LOW RETINAL DOPAMINE AND SERUM PROLACTIN LEVELS INDICATE AN INHERITED DOPAMINERGIC ABNORMALITY IN BW RATS
    WYSE, JPH
    LORSCHEIDER, FL
    EXPERIMENTAL EYE RESEARCH, 1981, 32 (05) : 541 - 551
  • [9] Reproductive experience modifies dopaminergic function, serum levels of prolactin, and macrophage activity in female rats
    Carvalho-Freitas, M. I. R.
    Anselmo-Franci, J. A.
    Teodorov, E.
    Nasello, A. G.
    Palenno-Neto, J.
    Felicio, L. F.
    LIFE SCIENCES, 2007, 81 (02) : 128 - 136
  • [10] EFFECTS OF CENTRAL ACTING DRUGS ON SERUM AND PITUITARY PROLACTIN LEVELS IN RATS
    LU, KH
    AMENOMORI, Y
    CHEN, CL
    MEITES, J
    ENDOCRINOLOGY, 1970, 87 (04) : 667 - +